Guidewheel Raises $8M in Series A Funding
26 Jul, 2021
– PEP-Therapy, a biotechnology company based in Paris, raised €3m in Series A funding.
– The funding was led by Anaxago, i&i Prague and BADGE as well as a €1m loan from Bpifrance.
– The company intends to use the funds to finance the Phase I a/b clinical trial of PEP-010, its lead candidate, for the treatment of advanced solid tumors.